Background: Use of oral contraceptives (OCs) may modulate the clinical course of women with congenital long QT syndrome (LQTS). The safety of OC use by sex hormone content has not been assessed in women with LQTS.
Objective: We aimed to evaluate the association of OCs with the risk of cardiac events (CEs) in women with LQTS.
Methods: Beginning in 2010, information on menarche onset, OC use, pregnancy, and menopause were obtained from women enrolled in the Rochester LQTS Registry. Type of OC was categorized as progestin-only, estrogen-only, or combined (estrogen/progestin). Andersen-Gill multivariate modeling was used to evaluate the association of time-dependent OC use with the burden of CE (total number of syncope, aborted cardiac arrest, and LQTS-related sudden cardiac death) from menarche onset through 40 years. Findings were adjusted for genotype, corrected QT duration, and time-dependent β-blocker therapy.
Results: A total of 1659 women with LQTS followed through March 2021, of whom 370 (22%) were treated with an OC. During a cumulative follow-up of 35,797 years, there were a total of 2027 CE. Multivariate analysis showed that progestin-only OC was associated with a pronounced 2.8-fold (P = .01) increased risk of CEs in women who did not receive β-blocker therapy, while β-blockers were highly protective during progestin-only OC treatment (hazard ratio 0.22; P = .01; P = .006 for β-blocker-by-OC interaction). The risk associated with OC use without concomitant β-blocker treatment was pronounced in women with LQTS type 2.
Conclusion: Our findings suggest that progestin-only OC should not be administered in women with LQTS without concomitant β-blocker therapy. OCs should be used with caution in women with LQTS type 2.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.hrthm.2021.07.058 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Congenital Long QT Syndrome Masquerading as Epilepsy: A Case Report.
Cureus
November 2024
Cardiology, Manchester University NHS Foundation Trust, Manchester, GBR.
In this case report, we present a 24-year-old woman with a previous diagnosis of epilepsy who was admitted to the hospital following loss of consciousness (LOC). It was initially assumed that this was an epileptic seizure based on her previous diagnosis of epilepsy; however, a review of her electrocardiograms (ECGs) revealed a prolonged QT interval. She was admitted to the cardiology ward for continuous ECG monitoring and subsequently developed self-limiting torsades de pointes (TDP).
View Article and Find Full Text PDFImpact of Beta-Blocker Therapy on Pregnant Women With Long QT Syndrome: A Systematic Review.
Cureus
October 2024
Obstetrics and Gynaecology, An-Najah National University, Nablus, PSE.
Long QT syndrome (LQTS) presents significant challenges for pregnant women due to the elevated risk of arrhythmic events. Beta-blocker therapy is a cornerstone of treatment in managing LQTS, but its use during pregnancy introduces potential fetal risks. This systematic review synthesizes the evidence on the efficacy and safety of beta-blocker therapy in pregnant women with LQTS.
View Article and Find Full Text PDFLow foetal heart rate, a potentially ominous finding: case report.
Eur Heart J Case Rep
September 2024
Department of Cardiothoracic Pathology, University of Medicine and Pharmacy Carol Davila, 8 Eroii Sanitari Blv., Bucharest 050474, Romania.
Article Synopsis
- * A case of a 25-year-old pregnant woman highlighted the importance of cardiac evaluation after foetal bradycardia was detected; she was diagnosed with LQTS type 1, and managed with medication and monitoring, resulting in a safe delivery.
- * Early detection of foetal heart rate irregularities is critical in pregnancies, as persistent low heart rates can indicate LQTS and may require careful management strategies to ensure
Multimodal fusion learning for long QT syndrome pathogenic genotypes in a racially diverse population.
NPJ Digit Med
August 2024
The Charles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Article Synopsis
- - The diagnosis of congenital long QT syndrome (LQTS) is challenging due to a lack of scalable genetic testing, low prevalence, and normal QT intervals in patients with risky genotypes.
- - Researchers developed a deep learning model that combines ECG waveform data and electronic health records to identify patients with harmful genetic variants indicating LQTS.
- - After training on UK Biobank data and refining the model with diverse cohorts, the approach achieved good accuracy in distinguishing individuals with pathogenic mutations, showing potential for better patient prioritization in clinical settings.
Emotional Awareness Is Correlated With Ambulatory Heart Rate Variability: A Replication and Extension.
Psychosom Med
November 2024
From the Department of Biobehavioral Health at Penn State University (Spangler), University Park, Pennsylvania; Department of Psychology at University of Rochester (Reis), Rochester, New York; Epidemiology and Biostatistics Department, University of Arizona College of Public Health, Tucson, Arizona (Hsu), Tucson, Arizona; Department of Medicine at University of Rochester Medical Center (Zareba), Rochester, New York; and Departments of Psychiatry, Psychology, and Neuroscience at University of Arizona (Lane), Tucson, Arizona.
Objective: In healthy volunteers, a positive association has previously been observed between emotional awareness (EA), the ability to identify and describe emotional experiences in oneself and others, and resting heart rate variability (HRV), which is dominated by vagus nerve activity. The current study aimed to investigate the EA-HRV association across multiple assessments in a "real-world" ambulatory context in patients with long QT syndrome (LQTS) who are at genetic risk for sudden cardiac death.
Methods: Participants (157 LQTS patients; Mean Age = 35.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!